Past Event

Should we revisit the patent system for pharmaceutical products?

Analysis of the legal issues with the current IP system for regulated market authorisations for pharmaceutical products, as well as its economic effects.

Date: July 9, 2018, 12:30 pm Topic: Innovation & Competition Policy

video & audio recordings

summary

The panel set themselves to address some fundamental questions about the European patent system and how it affects the pharmaceutical sector, as the pharmaceutical industry represents roughly 30% of all the EU R&D spending. They discussed the proposal put forward by the Commission about a reform of the supplementary protection certificate, which extends pharmaceutical companies’ patent protection for an additional 5 years maximum as a compensation for the years of patent term lost for the development of the patented product prior to effective market entry. In order to boost jobs creation in generics and biosimilars manufacturing and to alleviate some of the concerns about access to medicines, the reform would introduce a waiver for generic and biosimilar manufacturers’ exports outside the EU. This would allow them to manufacture generic and biosimilar versions of protected products and to sell them abroad without fees to patent-owners. The private sector is however concerned this initiative reduces IP rights, while recognizing the Commission’s efforts to introduce safeguards with regards to labelling and stockpiling.

The panel then discussed two studies that explored the legal and economic aspects of the proposed reforms. Economically, intellectual property protection in the pharmaceutical industry is found to incentivise innovation, but is negative for access to the molecules developed. Indeed, protection results in a significantly higher price compared to when competition from generic versions of the products enter the market. From a legal perspective, the reform is found to be necessary as the Court of Justice of the EU has taken decisions that have led to a divergence from the legal basis: reducing that divergence, either by codifying case law or addressing the ambiguities in the legal basis.

Participants then discussed some of the shortcomings of the current patent system in general. Some of the key issues of the current systems on which most participants seem to agree was the need to unify the EU intellectual property framework and the need to consider the global aspect of intellectual property legislation. Indeed, participants agreed that the current system is very fragmented, with 28 regulators, 28 sets of rules and 28 times the amount of administrative costs – for 28 nations that aspire to form a single market, this was perceived as inefficient. Furthermore, participants mentioned how other nations’ own legislative templates were influenced by the EU’s system and that there existed international agreements. These therefore limit the degrees of freedom the EU has to reform. However, the pharmaceutical industry clarified that duration of intellectual property protection was generally not a factor in selecting a location for establishing activities.

More broadly, participants and the audience discussed how other incentives for innovation in the EU had been left out of the debate, as well as fundamental problems. Because the real benefits of innovation cannot be known ex ante, intellectual property protection has always been a sort of trade-off between incentivisation and access. There was an agreement that, in addition of the traditional patent protection, other incentivisation mechanisms should be better leveraged for innovation, such as public funding for research, prizes, Europe-wide industrial policy, pricing policy or universities’ royalty system. In terms of more fundamental reforms of the patenting system, the audience suggested thinking of a system that factors in the profitability of innovation rather than merely the revenue side. They also highlighted the need to tackle “fake innovation” and abuse of the intellectual property system that stymies innovation, noting the importance of having transparent system with clear criteria for granting protection.

event materials

Study on the economic impact of supplementary protection certificates, pharmaceutical incentives and rewards in Europe, by Copenhagen Economics (call for tender 590/PP/GRO/SME/16/F/121)

Schedule

Jul 9, 2018

12:30-13:00

Check-in and lunch

13:00-14:00

Panel discussion

Chair: Reinhilde Veugelers, Senior Fellow

Arno Hartmann, Member of EFPIA's IP expert group

Christian Jervelund, Head Health Care and Life Sciences services, Copenhagen Economics

Margaret K. Kyle, Professor of Economics, Center for Industrial Economics (CERNA), MINES ParisTech (Ecole des Mines)

Roberto Romandini, Senior Research Fellow, Max Planck Institute for Innovation and Competition

Amaryllis Verhoeven, Head of Unit, Industrial Property and the Fight against Counterfeiting, European Commission

Bruno van Pottelsberghe, Non-Resident Fellow

14:00-14:30

Q&A

14:30

End

Speakers

Arno Hartmann

Member of EFPIA's IP expert group

Christian Jervelund

Head Health Care and Life Sciences services, Copenhagen Economics

Margaret K. Kyle

Professor of Economics, Center for Industrial Economics (CERNA), MINES ParisTech (Ecole des Mines)

Roberto Romandini

Senior Research Fellow, Max Planck Institute for Innovation and Competition

Bruno van Pottelsberghe

Non-Resident Fellow

Amaryllis Verhoeven

Head of Unit, Industrial Property and the Fight against Counterfeiting, European Commission

Reinhilde Veugelers

Senior Fellow

Location & Contact

Bruegel, Rue de la Charité 33, 1210 Brussels

Katja Knezevic

katja.knezevic@bruegel.org

Read about event More on this topic

Past Event

Past Event

Market power and its implications to competition policy

What are the reasons behind the global trends in corporate margins and market concentration?

Speakers: Adina Claici, Fiona Scott Morton, Nicolas Petit, Georgios Petropoulos and Arno Rasek Topic: Innovation & Competition Policy Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: January 16, 2019
Read about event

Upcoming Event

Feb
12
12:30

Is the European automotive industry ready for the global electric vehicle revolution?

How can Europe catch up on the global electric vehicle race?

Speakers: Simone Tagliapietra and Reinhilde Veugelers Topic: Energy & Climate, Innovation & Competition Policy Location: Bruegel, Rue de la Charité 33, 1210 Brussels
Read about event More on this topic

Past Event

Past Event

Investment and intangible capital

This event featured a presentation of the EIB's 2018 Investment Report.

Speakers: Román Arjona, Maria Demertzis, Debora Revoltella and Mario Nava Topic: European Macroeconomics & Governance Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: December 14, 2018
Read about event More on this topic

Past Event

Past Event

Emerging Trends in Competition Policy - A Global Perspective

How is global competition policy evolving given the challenges of the digital era?

Speakers: Cristina Caffarra, Antonio Capobianco, Kris Dekeyser, William Kovacic and Georgios Petropoulos Topic: Innovation & Competition Policy Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: December 11, 2018
Read about event More on this topic

Past Event

Past Event

Environmental and economic effects of the EU ETS

What is the impact of the EU ETS on carbon emissions and economic performance of regulated companies?

Speakers: Sander de Bruyn, Antoine Dechezleprêtre, Beatriz Yordi Aguirre and Georg Zachmann Topic: Energy & Climate Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: December 6, 2018
Read about event More on this topic

Past Event

Past Event

Civil society for the digital age

What is the place of civil society in the digital age as well as the role of technology in society?

Speakers: Eline Chivot, Orla Lynskey, Bertin Martens, Georgios Petropoulos, Thiébaut Weber and Glen Weyl Topic: Innovation & Competition Policy Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: December 4, 2018
Read about event More on this topic

Past Event

Past Event

How to speed up sustainable finance?

Which steps are needed to really change current practices and speed up sustainable finance?

Speakers: Sophie Barbier, Molly Scott Cato, Cathrine de Coninck-Lopez, Alain Deckers, Edmund Lakin and Dirk Schoenmaker Topic: Finance & Financial Regulation Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: November 28, 2018
Read about event More on this topic

Past Event

Past Event

Reviewing the EU fiscal framework

What are the positive and negative developments and is there scope for improvement?

Speakers: Niels Thygesen and Anne-Laure Delatte Topic: European Macroeconomics & Governance Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: November 22, 2018
Read about event More on this topic

Past Event

Past Event

Competition policy for the digital age

How can competition policy adapt to market changes caused by new technologies, digital platforms and big data companies?

Speakers: Ana Botin, Riccardo Falconi, Jorge Padilla, Tommaso Valletti and Reinhilde Veugelers Topic: Innovation & Competition Policy Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: November 21, 2018
Read about event

Past Event

Past Event

European Banking Supervision: the past five years and prospects for the future

This event will look back at the first five years of the Single Supervisory Mechanism.

Speakers: Danièle Nouy and Guntram B. Wolff Topic: European Macroeconomics & Governance, Finance & Financial Regulation Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: November 20, 2018
Read about event More on this topic

Past Event

Past Event

Does Europe’s anti-money laundering framework need a regime change?

Proposal for a more efficient fight against money laundering.

Speakers: Raluca Alexandra Pruna, Joshua Kirschenbaum, Tobias Mackie, Olaf Rachstein and Nicolas Véron Topic: Finance & Financial Regulation Location: Bruegel, Rue de la Charité 33, 1210 Brussels Date: November 15, 2018
Read about event More on this topic

Past Event

Past Event

Distributional effects of climate policies

How do we design climate policies to minimize adverse distributional effects?

Speakers: Elena Jachia, Elena Verdolini and Georg Zachmann Topic: Energy & Climate Location: Centro Congressi Fondazione Cariplo, Via Romagnosi, 8, 20121 Milano MI, Italy Date: November 14, 2018
Load more posts